Clinical Trial Update: Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of darolutamide combined with androgen deprivation therapy in high-risk localized prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Darolutamide (darolutamide)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN